BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17147124)

  • 1. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Lei W; Liang J; Chen WG; Ma XZ; Xu M; Du LL
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):542-4. PubMed ID: 17147124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Li L; Xu CG; Wang XW; Guo QS; Sun YH; Sun LM
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].
    Sun XF; Guan ZZ; Huang H; Zhou QH; Yi C; Zhang LJ; Zhu J; Li R; Zhou J; Zhang M; Guo Y
    Ai Zheng; 2002 Aug; 21(8):892-5. PubMed ID: 12478901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF; Yu J; Liu L; Wu G
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant human interleukin-11 in the prevention of chemotherapy-induced thrombocytopenia].
    Chu DT; Xu BH; Song ST; Mao XH; Jiao SC; Zhang AL
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):272-4. PubMed ID: 12839693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
    Cairo MS; Davenport V; Bessmertny O; Goldman SC; Berg SL; Kreissman SG; Laver J; Shen V; Secola R; van de Ven C; Reaman GH
    Br J Haematol; 2005 Jan; 128(1):49-58. PubMed ID: 15606549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
    Rinehart J; Margolin KA; Triozzi P; Hersh E; Campion M; Resta D; Levitt D
    Clin Cancer Res; 1995 Oct; 1(10):1139-44. PubMed ID: 9815905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
    Kaye JA
    Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and mechanism of rhIL-11 in the management of chemotherapy-induced thrombocytopenia in acute leukemia].
    Cui XL; Wang L; Gao J; Qin P; Shi Y; Peng J; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):345-7. PubMed ID: 16185478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia].
    Xu YJ; Chen FP; Li XL; Zhao XL; He Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):433-6. PubMed ID: 17611320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency, safety and tolerability of recombinant human interleukin-3 (rhIL-3) as supportive therapy accompanying dose-intensive carboplatin containing chemotherapy in ovarian cancer with special regard to thrombocytopenia].
    Meden H; Fock M; Krauss T; Kuhn W
    Zentralbl Gynakol; 1999; 121(8):375-83. PubMed ID: 10486880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
    Cantor SB; Elting LS; Hudson DV; Rubenstein EB
    Cancer; 2003 Jun; 97(12):3099-106. PubMed ID: 12784347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
    Isaacs C; Robert NJ; Bailey FA; Schuster MW; Overmoyer B; Graham M; Cai B; Beach KJ; Loewy JW; Kaye JA
    J Clin Oncol; 1997 Nov; 15(11):3368-77. PubMed ID: 9363868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
    Ghalib R; Levine C; Hassan M; McClelland T; Goss J; Stribling R; Seu P; Patt YZ
    Hepatology; 2003 May; 37(5):1165-71. PubMed ID: 12717398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of interleukin-11 on thrombocytopenia in patients with hematologic malignancies after chemotherapy].
    Zhang XL; Cheng XZ; Ye X; Shi XJ
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):713-5. PubMed ID: 21122391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.